Neurotop (Carbamazepine)

Carbamazepine, the active ingredient in Neurotop, is an anticonvulsant presented as an oral tablet for oral use. It works by reducing abnormal neuronal firing, making it useful for controlling seizures, relieving the intense facial pain of trigeminal neuralgia, and stabilizing mood swings in bipolar disorder.

GNH USA supplies Neurotop as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics across global markets with reliable quality and regulatory compliance through established distribution networks.

Neurotop (carbamazepine) is used in several neurological and psychiatric conditions that involve hyper‑excitable neuronal activity.

Epilepsy: reduces seizure frequency by stabilizing neuronal membranes. Trigeminal neuralgia: alleviates severe facial pain by decreasing nerve firing. Bipolar disorder: helps control mood swings by modulating neuronal excitability.

Carbamazepine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Drowsiness - Nausea - Diplopia (double vision) - Blurred vision - Skin rash

Serious or Rare Side Effects: - Agranulocytosis (dangerously low white‑blood‑cell count) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe hepatic failure - Blood dyscrasias such as aplastic anemia - Life‑threatening skin reactions - Severe hypersensitivity reactions

When prescribing Neurotop, clinicians should observe several safety measures to minimise risks.

Monitor blood counts: perform regular complete blood count tests to detect agranulocytosis early. Assess liver function: schedule periodic liver enzyme assessments. Avoid abrupt discontinuation: taper the dose under medical supervision to prevent seizure recurrence. Use caution in renal impairment: dose adjustment may be required based on renal function. Pregnancy: potential risks are unknown; discuss benefits and alternatives with the patient. Store at ambient temperature: keep in the original container, protect from moisture and light.

Carbamazepine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Erythromycin: may raise carbamazepine levels, increasing toxicity risk. - Azole antifungals (e.g., ketoconazole, fluconazole): inhibit metabolism, leading to higher concentrations. - CYP3A4 inhibitors (e.g., ritonavir): can cause significant accumulation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: carbamazepine reduces hormonal efficacy, risking unintended pregnancy. - Valproic acid: combined use may increase adverse effects such as dizziness and ataxia. - Rifampin: induces metabolism, potentially lowering carbamazepine effectiveness.